Absolute contraindication for combined oral contraceptive pill.

Question

09 Jan 2025

Answer :

Word Count : 569

Combined oral contraceptive pills (COCPs) are widely used for contraception and offer additional benefits, such as regulation of menstrual cycles and reduction in the risk of certain cancers. However, they are contraindicated in specific medical conditions where their use could result in significant harm. These contraindications are classified as "absolute" when the risks of COCPs outweigh any potential benefits.

### 1. Cardiovascular Disorders
- History of Thromboembolism: COCPs increase the risk of blood clot formation. Women with a history of deep vein thrombosis (DVT) or pulmonary embolism (PE) are at high risk of recurrence.
- Stroke or Ischemic Heart Disease: Individuals with a history of stroke or myocardial infarction are at increased risk due to the prothrombotic effects of COCPs.
- Uncontrolled Hypertension: Blood pressure above 160/100 mmHg significantly elevates the risk of stroke or cardiovascular _____ __________ __________ ________ ____ ______ _________ _____ _________ _______ _________.
_________ ______ ______ ___ ____.
__________ __________ ____ _______ ______ ___ __________ _______ _____ __________ ___ _____.
__________ _____ ____ __________ ______ _________ _________ _______ ___ ______.
__________ ______ __________ _____ ___ _________ _____ ______ ________ ___.
__________ ________ _____ _________ ____ ______ _______ _______ _____.
___ ________ _____ _________ ___ _______ ________ _____ _____ ___ _____.
_________ _____ ________ __________ ________ ___ ________ _________ ___ __________.
________ ______ _________ ____ ________ ____.
____ ____ _________ __________ ______ ____ _______.
___ ________ _____ ________ _________ ________ _____.
_____ _____ _________ __________ _________ _________ ________ _____ _________ _____.
_______ _______ ____ ______ _______ ___ _____ _______.
_________ ______ _____ _________ _____ ________.
_________ _________ _____ _________ ___ ___ ____ ________ _______ __________ _______.
__________ _________ ________ ______ ________ ________ __________ _____ ______ ___.
___ ______ _______ ______ ________ ___ ___ _____.
________ _______ _______ _______ ______ ___ __________.
___ ______ __________ ______ ____ ___ __________ _______ _____ _____ _____ ___.
__________ _________ ________ ___ _________ __________ ________.
_______ _________ ____ ________ ______ ________ ______.
____ ____ ______ ____ ________ ____ __________.
______ _________ __________ ____ __________ _________ ________ ____ ____.
_____ _________ ________ ________ _________ _______ ___ ________ ___ ___ ________.
_____ __________ _______ _____ __________ __________ ___ _________ ____ ________ _______.
__________ ___ _______ __________ ______ ___ ________ ______ _____ ________ ___.
____ ____ __________ ____ __________ ___ ___ _____.
_________ _________ _________ _____ __________.
_________ _________ ___ ______ __________ ____ _______ _______ ____.
__________ ____ _______ _______ _____ _____.
_____ ________ _______ ___ ___ ____ _____ _______ _______ ______ _____.
_____ ______ ___ _________ _______ __________.
_________ _________ __________ ____ ______ _______ ___ __________.
_________ _____ _____ _________ _______ _________ _____ ________.
______ __________ ____ _________ _____ ________ _________ ____ __________.
_________ _________ _______ _____ ___ ____ __________ ________ ________ _______ _________ _____.
________ _____ _________ ________ _________ _______ _____ _____.
_____ ___ ________ _______ ___ ___ ______.
___ __________ ______ ______ ______ _______ ___ ____.
_______ _________ ____ ________ __________ ___ ____ ______ __________ _____ ____.
_________ ________ ___ ____ ___.
___ ________ ______ ____ ______ _________ ____ ________.
______ ___ __________ _________ _______ _____ _______ ______.
___ ____ ____ ___ ______ _______ _________ _____ ___.
___ __________ ______ ____ ____ __________ ________.
_______ _________ ____ __________ ___ ________ ______ ______ ____ ________ ________ ______.
_________ _________ ___ ______ ___ ________ _______ _____ __________ ______ ________.
________ __________ __________ __________ _______ ______.
__________ _________ __________ _______ __________ _________.
______ _________ _________ ________ ___ _______.
Get Full Answer on WhatsApp

IGNOU Solved Assignments Assignments Ignou Projects Project Previous Year Solved Exam Papers Notes Notes Sample Question Papers Sample Question Papers

IGNOU NEWS

Assignment Submission Last Date Extended Till 30 June 2026 Click Here★★★IGNOU June 2026 TEE Date Sheet Released Click Here★★★